Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter

NACompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

December 1, 2016

Study Completion Date

January 12, 2017

Conditions
Eustachian Tube Dysfunction
Interventions
DEVICE

Acclarent Eustachian Tube Balloon Catheter (ETBC)

Trial Locations (21)

10021

Vijay Anand, LLC, New York

10601

Ear, Nose, Throat and Allergy Associates, LLP, White Plains

11777

Ear, Nose, Throat and Allergy Associates, LLP, Port Jefferson

20006

George Washington Medical Faculty Associates, ENT Center, Washington D.C.

27609

Carolina Ear and Hearing Clinic, Raleigh

28210

Charlotte Eye, Ear, Nose &Throat Associates, Charlotte

30308

ENT of Georgia, Atlanta

30309

Piedmont Ear, Nose & Throat &Related Allergy, Atlanta

33437

ENT of South Florida, Boynton Beach

33487

ENT of South Florida, Boca Raton

34239

Florida Ear & Sinus Center, Sarasota

39564

The Sinus Center of the South, Ocean Springs

46052

Witham Health Services, Lebanon

53716

Meriter Monona, Monona

55130

Health Partners Specialty Center, Saint Paul

70808

Our Lady of the Lake Hospital, Baton Rouge

71303

Red River Sinus Center, Alexandria

76104

Texas Healthcare, PLLC, Fort Worth

78240

Ear Medical Group, San Antonio

94303

California Ear Institute, East Palo Alto

02115

Children's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Acclarent

INDUSTRY

lead

Integra LifeSciences Corporation

INDUSTRY